Literature DB >> 12552092

Coordinate inhibition of expression of several genes for protein subunits of human nuclear RNase P.

Elizaveta Kovrigina1, Donna Wesolowski, Sidney Altman.   

Abstract

The deliberate inhibition of expression of one of the protein subunits (Rpp38) of human nuclear RNase P is achievable by using external guide sequence (EGS) technology. Both the protein product and the mRNA are greatly reduced 24 h after transient transfection with a gene coding for an appropriate EGS. Control experiments indicated that four other protein subunits of RNase P and their RNAs are also inhibited with no external manipulation. The remaining RNase P proteins, their mRNAs, and the RNA subunit of RNase P all are unchanged. Several short nucleotide sequences adjacent to the ORFs for the inhibited genes are similar and could be targets for transcriptional repression. The explanation of coordinate inhibition of the expression of the product of one particular gene by the transfection of an EGS (or RNA interference) requires some care in terms of interpreting phenotypic effects because, in our case, several gene products that are not targeted are also inhibited.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12552092      PMCID: PMC149878          DOI: 10.1073/pnas.0337661100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  A protein subunit of human RNase P, Rpp14, and its interacting partner, OIP2, have 3'-->5' exoribonuclease activity.

Authors:  Taijiao Jiang; Sidney Altman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

2.  Targeted cleavage of mRNA by human RNase P.

Authors:  Y Yuan; E S Hwang; S Altman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

Review 3.  Life at the edge: the nuclear envelope and human disease.

Authors:  Brian Burke; Colin L Stewart
Journal:  Nat Rev Mol Cell Biol       Date:  2002-08       Impact factor: 94.444

4.  Improved retroviral vectors for gene transfer and expression.

Authors:  A D Miller; G J Rosman
Journal:  Biotechniques       Date:  1989-10       Impact factor: 1.993

5.  External guide sequences for an RNA enzyme.

Authors:  A C Forster; S Altman
Journal:  Science       Date:  1990-08-17       Impact factor: 47.728

6.  Identification and characterization of an RNA molecule that copurifies with RNase P activity from HeLa cells.

Authors:  M Bartkiewicz; H Gold; S Altman
Journal:  Genes Dev       Date:  1989-04       Impact factor: 11.361

7.  Artificial regulation of gene expression in Escherichia coli by RNase P.

Authors:  C Guerrier-Takada; Y Li; S Altman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

8.  Modulation of the human protein kinase C alpha gene promoter by activator protein-2.

Authors:  Joannah Hackenbruck Clark; Vedanandam Haridasse; Robert I Glazer
Journal:  Biochemistry       Date:  2002-10-01       Impact factor: 3.162

Review 9.  Oligonucleotide conjugates as potential antisense drugs with improved uptake, biodistribution, targeted delivery, and mechanism of action.

Authors:  Muthiah Manoharan
Journal:  Antisense Nucleic Acid Drug Dev       Date:  2002-04

10.  Two RNA species co-purify with RNase P from the fission yeast Schizosaccharomyces pombe.

Authors:  G Krupp; B Cherayil; D Frendewey; S Nishikawa; D Söll
Journal:  EMBO J       Date:  1986-07       Impact factor: 11.598

View more
  9 in total

1.  Alterations in the intracellular level of a protein subunit of human RNase P affect processing of tRNA precursors.

Authors:  Amit Cohen; Robert Reiner; Nayef Jarrous
Journal:  Nucleic Acids Res       Date:  2003-08-15       Impact factor: 16.971

2.  Ribonuclease P.

Authors:  Sidney Altman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-27       Impact factor: 6.237

3.  Regulated expression of functional external guide sequences in mammalian cells using a U6 RNA polymerase III promoter.

Authors:  Elizaveta Kovrigina; Li Yang; Emmanuel Pfund; Sidney Altman
Journal:  RNA       Date:  2005-08-30       Impact factor: 4.942

Review 4.  External guide sequence technology: a path to development of novel antimicrobial therapeutics.

Authors:  Carol Davies-Sala; Alfonso Soler-Bistué; Robert A Bonomo; Angeles Zorreguieta; Marcelo E Tolmasky
Journal:  Ann N Y Acad Sci       Date:  2015-04-09       Impact factor: 5.691

Review 5.  Unexpected diversity of RNase P, an ancient tRNA processing enzyme: challenges and prospects.

Authors:  Lien B Lai; Agustín Vioque; Leif A Kirsebom; Venkat Gopalan
Journal:  FEBS Lett       Date:  2010-01-21       Impact factor: 4.124

Review 6.  Aminoglycoside interactions with RNAs and nucleases.

Authors:  L A Kirsebom; A Virtanen; N E Mikkelsen
Journal:  Handb Exp Pharmacol       Date:  2006

7.  Generation of an external guide sequence library for a reverse genetic screen in Caenorhabditis elegans.

Authors:  Qitao Yan; Rui Zhao; Wenlin Zheng; Changxin Yin; Bao Zhang; Wenli Ma
Journal:  BMC Biotechnol       Date:  2009-05-20       Impact factor: 2.563

8.  Gene silencing in the therapy of influenza and other respiratory diseases: Targeting to RNase P by use of External Guide Sequences (EGS).

Authors:  David H Dreyfus; S Mark Tompkins; Ramsay Fuleihan; Lucy Y Ghoda
Journal:  Biologics       Date:  2007-12

9.  Function and assembly of a chromatin-associated RNase P that is required for efficient transcription by RNA polymerase I.

Authors:  Robert Reiner; Natalie Krasnov-Yoeli; Yana Dehtiar; Nayef Jarrous
Journal:  PLoS One       Date:  2008-12-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.